| 1 |
Song A, Kim SJ, Kim MS, et al. Long-Term antithyroid drug treatment of Graves' disease in children and adolescents: a 20-year single-center experience[J]. Front Endocrinol (Lausanne), 2021, 12: 687834.
|
| 2 |
Havgaard Kjær R, Smedegård Andersen M, Hansen D. Increasing incidence of juvenile thyrotoxicosis in denmark: a nationwide study, 1998-2012[J]. Horm Res Paediatr, 2015, 84(2): 102-107.
|
| 3 |
Rodanaki M, Lodefalk M, Forssell K, et al. The incidence of childhood thyrotoxicosis is increasing in both girls and boys in Sweden[J]. Horm Res Paediatr, 2019, 91(3): 195-202.
|
| 4 |
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid, 2016, 26(10): 1343-1421.
|
| 5 |
Mooij CF, Cheetham TD, Verburg FA, et al. 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease[J]. Eur Thyroid J, 2022, 11(1): e210073.
|
| 6 |
张军霞, 向光大. 难治性甲亢的临床处理策略[J]. 临床内科杂志, 2019, 36(8): 508-510.
|
| 7 |
van Lieshout JM, Mooij CF, van Trotsenburg ASP, et al. Methimazole-induced remission rates in pediatric Graves' disease: a systematic review[J]. Eur J Endocrinol, 2021, 185(2): 219-229.
|
| 8 |
Kaplowitz PB, Vaidyanathan P. Update on pediatric hyperthyroidism[J]. Curr Opin Endocrinol Diabetes Obes, 2020, 27(1): 70-76.
|
| 9 |
Léger J, Gelwane G, Kaguelidou F, et al. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study[J]. J Clin Endocrinol Metab, 2012, 97(1): 110-119.
|
| 10 |
Ohye H, Minagawa A, Noh JY, et al. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution[J]. Thyroid, 2014, 24(2): 200-207.
|
| 11 |
Azizi F, Takyar M, Madreseh E, et al. Long-term methimazole therapy in juvenile Graves' disease: a randomized trial[J]. Pediatrics, 2019, 143(5): e20183034.
|
| 12 |
Kaguelidou F, Alberti C, Castanet M, et al. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment[J]. J Clin Endocrinol Metab, 2008, 93(10): 3817-3826.
|
| 13 |
Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J]. Thyroid, 2011, 21(6): 593-646.
|
| 14 |
131I治疗格雷夫斯甲亢指南(2021版)[J]. 中华核医学与分子影像杂志, 2021, 41(4): 242-253.
|
| 15 |
Perrild H, Grüters-Kieslich A, Feldt-Rasmussen U, et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study[J]. Eur J Endocrinol, 1994, 131(5): 467-473.
|
| 16 |
Levy WJ, Schumacher OP, Gupta M. Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment[J]. Cleve Clin J Med, 1988, 55(4): 373-382.
|
| 17 |
陈晓波, 宋福英. 儿童甲状腺功能亢进症的诊断、治疗及预后[J]. 中华实用儿科临床杂志, 2019, 34(8): 561-564.
|
| 18 |
Alexander EK, Larsen PR. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease[J]. J Clin Endocrinol Metab, 2002, 87(3): 1073-1077.
|
| 19 |
Burch HB, Cooper DS. Management of Graves disease: a review[J]. JAMA, 2015, 314(23): 2544-2554.
|
| 20 |
Rivkees SA. Pediatric Graves' disease: controversies in management[J]. Horm Res Paediatr, 2010, 74(5): 305-311.
|
| 21 |
Breuer CK, Solomon D, Donovan P, et al. Effect of patient Age on surgical outcomes for Graves' disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center[J]. Int J Pediatr Endocrinol, 2013, 2013(1): 1.
|
| 22 |
Barczyński M, Konturek A, Hubalewska-Dydejczyk A, et al. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up[J]. Br J Surg, 2012, 99(4): 515-522.
|
| 23 |
Liu ZW, Masterson L, Fish B, et al. Thyroid surgery for Graves' disease and Graves' ophthalmopathy[J]. Cochrane Database Syst Rev, 2015, 25(11): CD010576.
|
| 24 |
Bobanga ID, McHenry CR. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(4): 101319.
|
| 25 |
张燕. 超声引导下甲状腺结节射频消融术[J/OL]. 中华医学超声杂志(电子版), 2021, 18(11): 1128.
|
| 26 |
罗渝昆, 张明博, 阎琳, 等. 甲状腺结节超声引导下热消融治疗的研究进展[J/OL]. 中华医学超声杂志(电子版), 2021, 18(9): 817-821.
|
| 27 |
甲状腺良性结节解剖位置分类与热消融风险防控专家共识[J/OL]. 中华医学超声杂志(电子版), 2020, 17(1): 6-10.
|
| 28 |
Li L, Qiu X. Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children: a retrospective study of 62 patients with over four years of follow-up[J]. Thyroid, 2022, 32(5): 525-535.
|
| 29 |
Zhou M, Ta S, Hahn RT, et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy[J]. JAMA Cardiol, 2022, 7(5): 529-538.
|
| 30 |
Liu F, Liu Y, Peng C, et al. Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study[J]. Eur Radiol, 2022, 32(11): 7743-7754.
|
| 31 |
Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study[J]. Eur Radiol, 2019, 29(10): 5607-5616.
|
| 32 |
Zhang L, Zhang GP, Zhan WW, et al. The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma[J]. Front Endocrinol (Lausanne), 2022, 13: 921812.
|
| 33 |
陈永花,梁黎,方燕兰,等.碘131联合射频消融治疗儿童甲状腺功能亢进症伴重度甲状腺肿一例[J]. 浙江大学学报(医学版), 2017, 46(1): 89-91.
|
| 34 |
Zhu JE, Zhang HL, Yu SY, et al. US-guided percutaneous microwave ablation for hyperthyroidism and immediate treatment response evaluation with contrast-enhanced ultrasound[J]. Clin Hemorheol Microcirc, 2021, 79(3): 435-444.
|
| 35 |
石文媛,陈佳佳,张潇,等.超声引导经皮微波消融治疗儿童难治性甲状腺功能亢进症1例[J]. 中华超声影像学杂志, 2022, 31(8): 730-732.
|